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Pathological Study on the Possible Pathogenesis of 
 Seizure-Induced Neuronal Damage in the Epileptic Brain 
Masashi Sakurai 
   Epilepsy is a chronic neurological condition characterized by recurrent seizures. 
Anti-epileptic drugs are major therapies for treatment of epileptic patients. However, 
these drug therapies target its symptoms rather than the underlying cause. 
Approximately 30 percent of epilepsy patients do not have seizure remission despite 
appropriate drug therapies (intractable epilepsy). In addition to the recurrent seizures, 
the intractable epilepsy patients have been reported to suffer from sequellae of brain 
dysfunctions, such as memory loss, language impairment, depression and olfactory 
dysfunction. These brain dysfunctions are considered to be caused by seizure-induced 
neuronal death. However, the pathogenesis of seizure-induced neuronal death was still 
unknown. To investigate a possible pathogenesis of seizure-induced neuronal death, the 
cerebrum of the familial Shetland Sheepdogs and kainic acid-treat rat (an animal model 
of epilepsy) was examined using histopathological and immunohistochemical methods. 
In the cerebrum of the familial Shetland Sheepdogs, angiogenesis and microglial 
activation were found consistent with the distribution of seizure-induced neuronal death 
with glutamate transporter 1 (GLT-1) downregulation. In the cerebrum of kainic acid-
treated rat, GLT-1 downregulation and microglial activation was found consistent with 
the distribution of seizure-induced neuronal death. Further, these pathological changes 
were observed in the same regions before neuronal death was detected. These results 
indicate that seizures can induce various pathological changes in the brain after seizures, 
which includes both neuroprotective (angiogenesis) and neurodestructive effects 
(microglial activation and GLT-1 downregulation). Glutamate excitotoxicity due to 
GLT-1 downregulation is considered to be a cause of seizure-induced neuronal death. 
The information from these studies may lead to deeper understanding of epilepsy and 
development of treatment for epilepsy. 
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GENERAL INTRODUCTION AND BACKGROUND 
1. Epilepsy 
   Epilepsy is a chronic neurological condition characterized by recurrent seizures due 
to neuronal hyperactivity (Blume et al., 2001). With its high prevalence, epilepsy is 
highly interested neuronal disease in the world (4 to 10 per 1,000 persons) (Sander et 
al., 2003). Anti-epileptic drugs are major therapies for treatment of epileptic patients. 
However, these drug therapies target its symptoms rather than the underlying cause. 
Moreover, approximately 30% of epilepsy patients do not have seizure remission 
despite appropriate drug therapies (intractable epilepsy) (Kwan et al., 2000).  
Temporal lobe epilepsy (TLE), refers to an electroclinical syndrome in which 
seizures arises from the temporal lobe. TLE is a prominent and prevalent epilepsy 
syndrome in children, adolescents and adults (Goldberg et al., 2013). 
2. Seizure-induced neuronal death and brain dysfunctions 
induce neuronal death in the cerebrum (Fujikawa et al., 2000; Meldrum et al., 1993). In 
the cerebrum of TLE patients and animal models of TLE, seizure-induced neuronal 
death spread in the limbic and limbic-related structures where seizure activity arises 
from (Duncan, 2002; Holmes, 2002). In addition to the recurrent seizures, TLE patients 
has been reported to suffer from sequellae of brain dysfunctions, such as memory loss, 
language impairment, depression and olfactory dysfunction (Alessio et al., 2006; Jacek 
et al., 2007; Kanner et al., 2011). Limbic and limbic-related structures have an 
important role in memory, language, decision-making and olfactory functions 
(McKenna et al., 2004; Tham et al., 2009; Vertes et al., 2002). The seizure-induced 
neuronal death in limbic and limbic-related structures may be responsible for the 
sequellae (Figure 1). However, the pathogenesis underlying seizure-induced neuronal 
death remains still unclear.
3. Possible Pathogenesis of seizure-induced neuronal death
Recent studies suggest that there are several pathological changes underlying 
seizure-induced neuronal death in epileptic brains (Figure 2). 
3.1. Glutamate excitotoxicity 
   Glutamate is known as an excitatory neurotransmitter that relates number of 
essential phenomena associated with neural functions. On the other hand, glutamate is 
also known as a neurotoxin that induces neuronal degeneration and neuronal death due 
to overstimulation of glutamate receptors (Balkhi et al., 2014).  
In epileptic brain, electroencephalography (EEG) analysis shows epileptic 
discharges that indicate neuronal hyperexcitation during seizures and also interictal 
period (Herman et al., 2011; Salami et al., 2014). Seizure-induced neuronal death is 
distributed along with the regions where seizure activity arises from (Duncan, 2002; 
Holmes, 2002). Further, glutamate transporter 1 (GLT-1) has been reported to be 
downregulated in epileptic brains (Proper EA et al., 2002; Dutuit M et al., 2002; 
Samuelsson C et al., 2000). GLT-1 is important for astrocytic glutamate uptake and 
GLT-1 downregulation has been reported to induce glutamate excitotoxicity (Rothstein 
et al., 1994; Sonnewald et al., 1997). Therefore, glutamate excitotoxicity might play an 
important role in the induction of seizure-induced neuronal death in epileptic brain. 
3.2. Seizure-induced blood flow alterations 
   Recent papers describe dynamic blood flow alternation in the epileptic brain during 
seizures (Dupont et al., 2009), and focal hypoperfusion has been considered as a cause 
of neuronal death (Choy et al., 2010). Hypoperfusion and ischemia are well known to 
induce neuronal death in the brain (Walton et al., 1999). It is possible that a local 
hypoperfusion or ischemia is part of the pathophysiological process that underlies the 
seizure-induced neuronal death.  
3.3. Blood-brain barrier breakdown 
Blood brain barrier is a structure that limits the penetration of a variety of 
substances from the blood into the brain. This structure is composed of vascular 
endothelium and astrocytic feet, and protects brain physically and physiologically 
(Abbott et al., 2010). Recent papers describe that an increase of blood-brain barrier 
permeability that leads to blood-brain barrier breakdown occurs in the cerebrum of 
animal models of epilepsy (Oby et al., 2006). Further, blood-brain barrier breakdown 
has been reported to relate with the progression of epilepsy (van Vliet et al., 2007). 
3.4. Neuroinflammation (glial activation) 
   In the epileptic brain, glial cell (mostly microglia and astrocytes) has been reported 
to be activated focally by seizures (Wetherington et al., 2008; Rizzi et al., 2003). These 
activated glial cells express pro-inflammatory cytokines, such as tumor necrosis factor 
alpha, interleukin 1 beta and interleukin 6 (Vezzani et al., 2008a). The pro-inflammatory 
cytokines has been reported to induce neurodegenerative effects (Brown et al., 2010; 
Vezzani et al., 2008b; Rijkers et al., 2009). Also, nitric oxide synthase expression in the 
activated glial cells suggests oxidative stress to neuros in the epileptic brain (Herberg et 
al., 1995).  
4. Epilepsy in animals 
Epilepsy is one of the most common neuronal diseases also in animals (Thomas, 
2010). As same as human epilepsy, anti-epileptic drugs are major therapies for epileptic 
animals and there are some reports of intractable epilepsy in animals (Buckmaster, et 
al., 2002). Histologically, neuronal death is a characteristic finding in the cerebrum of 
epileptic animals (Morita et al., 2002; Kuwabara et al., 2010).To our knowledge, no 
brain dysfunctions are reported in epileptic animals, however, some report demonstrates 
learning deficits and depression-like behaviors in an animal model of epilepsy (Lee et 
al., 2001; Sarkisova,2003). 
4.1. Familial epileptic Shetland Sheepdogs in Tottori University (Figure 3) 
In the department of Veterinary Pathology in Tottori University, familial epileptic 
Shetland Sheepdogs are kept. These familial dogs clinically showed epileptic discharges 
on EEG analysis, however, some of them had seizures while others did not. Histological 
examination revealed that neuronal death was present in the specific regions of the 
cerebrum of the dogs having seizures (Morita et al., 2002). In addition to the seizure-
induced neuronal death, immunohistochemistry suggested that GLT-1 downregulation 
had strong relationship to the neuronal death (Morita et al., 2005). As described above , 
GLT-1 downregulation has been reported to induce glutamate excitotoxicity (Rothstein 
et al., 1994; Sonnewald et al., 1997). Threrefore, GLT-1 downregulation is considered 
to be a cause of the seizure-induced neuronal death in the cerebrum of familial epileptic 
Shetland Sheepdogs.   
5. Animal models of epilepsy 
   In rodents (rats and mice), status epilepticus can be initiated by use of electrical 
stimulation (kindling) or chemical convulsants (Buckmaster, 2004). In the cerebrum of 
these animal models, several pathological changes including neuronal death and glial 
activation have been reported to be similar to those of humans (Buckmaster, 2004; 
Curia, et al., 2008; Levesque et al., 2013) 
6.1. Kindling model (Figure 4) 
Kindling means repeated, mild, electrical stimulation of the limbic or limbic-related 
structures, such as amygdala, olfactory regions and hippocampus, to induce a 
progressive and permanent seizure response. With repeated stimulation, after discharges 
extented and rats began displaying recurrent seizure (status epilepticus), despite 
unaltered stimulation parameters (Morimoto et al., 2004). Then, after a latent period, 
many of the animals start to show spontaneous recurrent seizures (Buckmaster, 2004).  
6.2. Chemical induction models (Figure. 5)
   Chemical convulsants such as pilocarpine and kainic acid can induce seizures in 
rodents. Pilocarpine is a muscarinic acethylcholine receptor agonist and kainic acid is a 
glutamate receptor agonist. Systemic injection of these chemicals can stimulate neurons 
in the brain and increases neuronal excitability, which results in recurrent seizures 
(status epilepticus) (Curia, et al., 2008; Levesque et al., 2013). Then, after an average 
latent period off approximately 26 days, many of the animals start to show spontaneous 
recurrent seizures (Buckmaster, 2004).  
Figure 1. Schematic diagram shows the relationship between seizure-induced neuronal 
death and brain dysfunctions.  
Figure 2. Schematic diagram of possible cause of seizure-induced neuronal death. 
Several pathological changes are thought to underlie the mechanism of seizure-induced 
neuronal death in the epileptic brain during or after seizure. 
Figure 3. Clinical and histological findings of the familial Shetland Sheepdogs in 
Tottori University. All the dogs had abnormal electroencephalography, however, 
neuronal death was found only in the cerebrum of the dogs having seizures (black dot in 
coronal plane of the cerebrum). 
Figure 4. Schematic diagram of kindling model.   
Figure 5. Schematic diagram of chemical induction model.  
OBJECTIVE AND STRUCTURE OF THE THESIS 
To study the possible pathogenesis of seizure-induced neuronal death, the cerebrums 
of Shetland Sheepdogs with familial epilepsy and kainic acid-treated rat were examined. 
GLT-1 expression was the most interested factor because the previous study in the 
cerebrum of the familial epileptic Shetland Sheepdogs strongly suggested the 
relationship between neuronal death and GLT-1 downregulation.  
In chapter 1: To investigate pathological changes, which might be relevant to GLT-1 
downregulation in the cerebrum of familial Shetland Sheepdogs, we performed 
histopathological and immunohistological examinations for angiogenesis and microglial 
activation.  
In chapter 2: To investigate the lesions of neuronal death and GLT-1 downregulation at 
different time-points after seizures, we studied lesions in the thalamus of kainic acid-
treated rat.  
Figure. Structure of the thesis 
LIST OF ORIGINAL PUBLICATIONS 
The thesis is based on the following original publications. 
    Sakurai M., Morita T., Takeuchi T., and Shimada A. (2013). Relationship of 
angiogenesis and microglial activation to seizure-induced neuronal death 
in the cerebral cortex of Shetland Sheepdogs with familial epilepsy. Am J 
Vet Res 74, 763-770. 
Sakurai M., Kurokawa H., Shimada A., Nakamura K., Miyata H., and Morita T. 
(2014). Excitatory amino acid transporter 2 downregulation correlates with 
thalamic neuronal death following kainic acid-induced status epilepticus 
in rat. Neuropathology In press. 
CHAPTER 1 
Relationship of angiogenesis and microglial activation to seizure-induced neuronal 
death in the cerebrum of familial epileptic Shetland Sheepdogs 
ABSTRACT 
   To examine angiogenesis and microglial activation in the cerebral lesion of familial 
epileptic Shetland Sheepdogs, ten dogs (six dogs with seizures and four dogs without 
seizures) were examined. Histological examination revealed that seizure-induced 
neuronal death was present in the cingulate cortex and cerebral cortex surrounding sulci. 
In and around the lesions, an increased number of microvessels was observed in the 
cerebrum of familial dogs with seizures. The microvessels appeared longer and more 
tortuous than those of dogs without seizures. Immunohistochemically, both neurons and 
glial cells in the lesions were positive for vascular endothelial growth factor (VEGF). 
Iba-1-positive microglia were also increased and morphologically activated in and 
around the lesions of seizure-induced neuronal death. Double immunofluorescence 
revealed that the activated microglia were positive for tumor necrosis factor-alpha, 
interleukin-6, and VEGF receptor 1. These findings were not observed in the cerebrum 
of familial dogs without seizures. Our results indicated that angiogenesis and microglial 
activation are thought to be related to seizure-induced neuronal death in the cerebrum of 
familial epileptic Shetland Sheepdogs. VEGF-induced microglial activation with pro-
inflammatory cytokine production may accelerate seizure-induced neuronal death. 
INTRODUCTION 
   Epilepsy is one of the most common neurological disorders in human and animals. 
Epileptic patients show chronic recurrent seizures and are sometimes associated with 
brain dysfunction (e. g. memory loss, language impairment and olfactory dysfunction) 
(Alession et al., 2006; Ciumas et al., 2008; Jacek et al., 2007). It has been reported that 
seizures induce neuronal death in the cerebrum human epilepsy and animal models of 
epilepsy (Fujikawa et al., 2000; Gorter et al., 2003; Wang et al., 2008). Seizure-induced 
neuronal death has been thought to be responsible for the brain dysfunction (Sutula et 
al., 1994). In addition, seizure-induced neuronal death has been reported to contribute 
the induction of subsequent seizures (Nairismägi et al., 2004; van Viet et al., 2004). 
However, the pathogenesis of seizure-induced neuronal death is still unknown, and an 
appropriate treatment for avoiding the seizure-induced neuronal death is not established.  
Recently, seizure has been reported to induce angiogenesis and microglial 
activation, which are thought to be related to neuronal death (Rigau et al., 2008; 
Avignone et al., 2008; Crespel et al., 2002). Angiogensis is associated with an increase 
of local blood flow and is thought to be neuroprotective (Ndode-Ekane et al., 2010). 
However, VEGF, an important angiogenic factor, has neurodegenerative effects such as 
induction of neuroinflammation and blood-brain barrier breakdown (Rigau et al., 2007; 
Croll et al., 2004). Neuroinflammation is the term used to describe the central nervous 
system inflammatory responses produced by activated glial cells. Activated microglia is 
major source of pro-inflammatory cytokines such as TNF- -6 (Vezzani et al., 
2008). These cytokines are associated with neuronal damage in several neurological 
(Allan et al., 2001; Heneka et al., 2010; Kiaei et al., 2006). 
In a colony of familial epileptic Shetland Sheepdogs, all of the familial dogs showed 
abnormal activity on electroencephalography, but some dogs had seizures while others 
did not. The purpose of the current study is to examine whether angiogenesis and 
microglial activation are related to the seizure-induced neuronal death in the brain of 
familial epileptic Shetland Sheepdogs. 
MATERIALS AND METHODS 
Animals 
Ten familial Shetland Sheepdogs and four age-matched non-familial Shetland 
Sheepdogs were used in this study. The familial dogs were classified into 2 groups; six 
familial dogs with a history of recurrent seizures ranging in age from 1 year 8 months to 
5years (No. 1-6) and four familial dogs without seizure ranging in age from 1 year 9 
months to 4 years 5 months (No. 7-10). In addition four non-familial Shetland 
Sheepdogs, ranging in age from 2 years 4 months to 4 years 7 months, were used as 
control dogs (No. 11-14). A previous study described about clinical history of the 
familial dogs with seizures (e.g. seizure onset, ictal period and seizure frequency) 
(Morita T et al., 2002). It was also described that all familial dogs (No. 1-10) showed 
abnormal activity on electroencephalography whereas 6 dogs (No. 1-6) with seizures 
histologically had acute neuronal change (ischemic-like change; shrunken eosinophilic 
cytoplasm and loss of nucleus) and astrocytosis in the cerebrum (Morita T et al., 2002). 
Clinically and histologically, no significant changes were detected in the brain of 
control dogs. A conventional vaccination schedule was followed and a monthly 
heartworm (Dirofilaria immitis) preventive treatment was administered. Appropriate 
veterinary care was provided if a generalized seizure occurred. This study was carried 
out with the approval of the Animal Research Committee, in accordance with the 
guidelines for animal experimentation of the Faculty of Agriculture, Tottori University. 
Histopathology and immunohistochemistry 
Complete postmortem examination was performed on all the dogs, and systemic 
organs were fixed in 10% neutral phosphate-buffered formalin. Cerebral tissues were 
sectioned coronally in 4 mm intervals from the frontal lobe to the occipital lobe. The 
tissues w hematoxylin 
and eosin staining and immunohistochemistry.  
Immunohistochemical analysis was performed with the labeled streptavidin-biotin 
(LSAB) method and the double-label immunofluorescence method, using primary 
antibodies listed in Table 1. After deparaffinization, the sections were transferred into 
citric acid buffer and boiled for 20 min at 98°C in a microwave (MI-77, Azuma, Tokyo, 
Japan) for antigen retrieval according to a standard microwave treatment protocol. For 
the LSAB method, after blocking endogenous peroxidase activity with 3% hydrogen 
peroxide for 15 min, sections were preincubated with 10% normal goat serum for 5 min 
in the microwave. Then, the sections were incubated with a primary antibody in 
appropriate treatment for each antibody. Sections were sequentially incubated with 
biotinylated goat anti-rabbit IgG antibody (Dako, Glostrup, Denmark; diluted 1:400) or 
biotinylated goat anti-mouse IgG antibody (Dako; diluted 1:400) as a second antibody 
for 5 min in the microwave, and then incubated with peroxidase-labeled streptavidin 
complex (Dako) for 5 min in the microwave. The reaction was revealed using 3,3´-
diaminobenzidine tetrahydrochloride (Dako). Sections were counterstained lightly with 
-label immunofluorescence method, Alexa Fluor 
488-conjugated goat anti-rabbit IgG antibody (Life technologies, Carlsbad, CA, USA; 
diluted 1:100) and Alexa Fluor 555-conjugated donkey anti-mouse IgG antibody (Life 
technologies; diluted 1:100) were used as second antibodies. After preincubation with 
normal goat serum for 5 min in the microwave, sections were incubated with rabbit anti-
Iba-1 or rabbit anti- GFAP primary antibody, and then incubated with Alexa Fluor 488-
conjugated goat anti-rabbit IgG second antibody for 1h at room temperature. Next, 
sections were incubated with an anti-mouse primary antibody (Table 1) and then 
incubated with Alexa Fluor 555-conjugated donkey anti-mouse IgG second antibody for 
1h at room temperature. Sections were mounted in plain 80% tris-buffered glycerol. 
Analysis was performed with a confocal imaging system (AX-70, Olympus 
Corporation, Tokyo, Japan). Nonspecific stain was estimated by replacing the primary 
antibody with phosphate-buffered saline.  
Statistical analysis 
Statistical analyses on severity of acute neuronal change, on number of microvessels 
and on relationship between the severity of acute neuronal change and the number of 
IL-6-positive cells were performed in the cingulate cortex of the familial dogs and 
control dogs. For the statistical analysis on severity of acute neuronal change, using a 
section stained with H&E stain (at the coronal level of corpus mamillare), each 5 fields 
of the cingulate cortex and cortex around the sulci (there were no overlaps) were 
randomly displayed at 200× magnification for each dog with seizure. Normal neurons 
(had large nucleus with prominent nuclear body and large cytoplasm with Nissl bodies) 
and neurons with acute change were counted, and the mean percentage of neurons with 
acute change was calculated. For the statistical analysis on number of microvessels, 
using a section immunohistochemically stained with vWF antibody (at the coronal level 
of corpus mamillare), 10 fields of the cingulate cortex (there were no overlaps) were 
randomly displayed at 400× magnification for each case (BX-51, Olympus Corporation, 
Tokyo, Japan). The number of microvessels was counted. The mean number of 
microvessels was calculated for each case and each group and compared using the 
-test (normal distribution was checked by Kolmogorov-Smirnov test and 
equal variance was checked by F-test). For the statistical analysis on relationship 
between the severity of acute neuronal change and the number of IL-6-positive cells, the 
severity of acute neuronal change was defined by the number of neurons with acute 
¬¬9 neurons with 
greater than 19 neurons with acute change. In the cerebrum of the familial dogs with 
seizures, 10 fields of each severity of acute neuronal change were randomly observed in 
400× magnification and IL-6-positive cells were counted. The means number of IL-6-
positive cells was calculated for each severity of acute neuronal change and compared 
-test (normal distribution was checked by Kolmogorov-Smirnov 
test and equal variance was checked by F-test). 
RESULTS 
Histologically, acute neuronal change (ischemic-like change; shrunken eosinophilic 
cytoplasm and loss of nucleus) were observed in the cerebrum of the familial dogs with 
seizures, but not found in the cerebrum of either the familial dogs without seizures or 
control dogs (Fig. 1). The neurons with acute change were localized in the cingulate 
cortex and cerebral cortex surrounding sulci. In the familial dogs with seizures, 
microvessels appeared longer more and tortuous than those of the familial dogs without 
seizures in and around the areas of acute neuronal change (Fig. 2A, B). Occasionally, 
the microvessels were surrounded by oval to flat cells, which were 
immunohistochemically positive for vWF (Fig. 2C, D). In the cingulate cortex of the 
familial dogs with seizures, the number of microvessels was significantly increased 
compared to the familial dogs without seizures and control dogs, whereas there were no 
significant differences between the familial dogs without seizures and control dogs (Fig. 
3). Immunohistochemically, in the familial dogs with seizures, glial cells and neurons 
were positive for VEGF in the cingulate cortex and cerebral cortex around sulci whereas 
VEGF-positive cells were not found in either the cerebrum of the familial dogs without 
seizures or control dogs (Fig. 4). The double-label immunofluorescence method 
revealed that VEGF-positive glial cells were both Iba-1-positive microglia and GFAP-
positive astrocytes (Fig. 5).  
Comparing the familial dogs with seizures and the familial dogs without seizures, an 
increased number of Iba-1-positive microglia was detected in the cingulate cortex and 
cerebral cortex surrounding sulci in the familial dogs with seizures. These microglia 
were morphologically activated (i.e. had swollen cell bodies and longer processes) (Fig. 
6). The double-label immunofluorescence method revealed that activated microglia 
were positive for VEGFR-1, TNF -6 (Figs. 7A, 8A, 9A). 
The distribution of VEGF-positive cells and activated microglia was similar to that 
of neurons with acute change, in addition, VEGF-positive cells and activated microglia 
were also observed in the areas surrounding neurons with acute change (Fig. 10). 
In the familial dogs with seizures, IL-6-positive immunolabelings were detected not 
only in microglia but also in neurons (except neurons with acute change) and GFAP-
positive astrocytes in the cingulate cortex and cerebral cortex surrounding sulci of the 
familial dogs with seizures (Figs. 9B, 11A). IL-6-positive cells were not found in either 
the cerebrum of the familial dogs without seizures or control dogs (Fig. 11B). Statistical 
analysis indicated that the number of IL-6-positive cells was significantly increased in 
connection with the severity of acute neuronal change (Fig. 12). VEGFR-1-positive 
immunolabeling and TNF- -positive immunolabeling were not detected in GFAP-
positive astrocytes (Fig. 7B, 8B).  
DISCUSSION 
In this study, histopathologic and immunohistochemical examination demonstrated 
that acute neuronal change, angiogenesis and microglial activation were localized in the 
cingulate cortex and cerebral cortex surrounding sulci of familial dogs with seizures. 
The acute neuronal change was thought to be seizure-induced neuronal death because it 
was not detected in the familial dogs without seizures. Production of VEGF in neurons 
and glial cells, long and tortuous microvessels, proliferation of vWF-positive vascular 
endothelial cells, and an increase in the number of microvessels have all been reported 
to be related to angiogenesis (Rigau et al., 2007; Nodode-Ekane et al., 2010). 
Morphologic changes in microglia (swollen cell bodies and long processes) and pro-
inflammatory cytokine production suggested microglial activation (Avignone et al., 
2008). In this study, pro-inflammatory cytokine production was immunohistochemically 
detected in the cerebrum of familial dogs with seizures. TNF- -positive 
immunolabeling was detected in activated microglia. TNF-
neurotoxicity by down-regulation of astrocytic glutamate transporter 1 (GLT-1)
(Carmen et l., 2009) (an important transporter for astrocytic glutamate uptake from the 
synaptic cleft (Rothstein et al., 1994; Sonnewald et al., 1997), and the induction of 
excess glutamate release due to microglial activation in an autocrine manner has been 
described (Takeuchi et al., 2006). In the cerebrum of familial dogs with seizures, a 
previous study demonstrated a high concentration of glutamate in the cerebrospinal 
fluid (Morita et al., 2002), a decrease in the immunopositivity of GLT-1 and excess 
glutamate immunopositivity in almost the same distribution as that of acute neuronal 
change and activated microglia (Morita et al., 2005). Glutamate is an excitatory 
neurotransmitter and excess glutamate is known to induce neurotoxicity, called 
excitoneurotoxicity (Rajdev et al., 1994). TNF-  was induced in the activated 
microglia, could cause glutamate metabolism dysfunction, leading to neuronal death. 
IL-6-positive immunolabeling was detected in activated microglia, and also in neurons 
and astrocytes in the cerebrum of familial dogs with seizures. Neuronal hyper-
excitability has been reported to induce neuronal production of IL-6 (Sallmann et al., 
2000) and IL-6 has been thought to have both direct and indirect neuroprotective effects 
against neuronal hyper-excitability (Gradient et al., 1997; Vezzani et al., 2008b; 
Yamada et al., 1994). However, in the cerebrum of familial dogs with seizures, IL-6-
positive cells were observed in almost the same distribution as that of acute neuronal 
change, and the increase in the number of IL-6-positve cells was related to the severity 
of acute neuronal change. The increased number of IL-6-positive cells reflected an 
increase in the number of IL-6-positive glial cells, because neurons with acute change 
were negative for IL-6. Overproduction of IL-6 in glial cells has been reported to cause 
neuronal death (Campbell et al., 1993). In the cerebrum of familial dogs with seizures, 
production of IL-6 in the glial cells may cause local overproduction of IL-6, resulting in 
neuronal death. Thus, microglial activation with pro-inflammatory cytokine production 
was thought to be responsible for the seizure-induced neuronal death in the cerebrum of 
familial dogs with seizures. 
In the cerebrum of familial dogs with seizures, neurons, astrocytes and microglia 
were immunohistochemically positive for VEGF. Production of VEGF in neurons and 
astrocytes has been reported to be induced by seizures in human epilepsy and in animal 
models of epilepsy, and VEGF is thought to contribute to angiogenesis for 
neuroprotection (van Vliet et al., 2007; Ndode-Ekane et al., 2010). However, in this 
study, the distribution of the VEGF-positive cells was consistent with that of the 
activated microglia and the activated microglia were immunohistochemically positive 
for VEGFR-1. VEGF has been reported to activate microglia via VEGFR-1 and induce 
an inflammatory response (Croll et al., 2004; Forstreuter et al., 2002). In addition, TNF-
-6 have been reported to be induced by VEGF via VEGFR-1 in macrophages 
and monocytes (Yoo et al., 2005). Recently, monocytes in the bloodstream have been 
thought to enter the brain during embryonic development and differentiate into 
microglia displaying many cell surface antigens found in macrophages (Kim et al., 
2005). In the cerebrum of the familial dogs with seizures, VEGF produced in neurons 
and astrocytes could activate microglia and induce overproduction of TNF- -6 in 
microglia. Moreover, recent evidence suggests that microglia are not only responsive to, 
but also sources of VEGF (Ryu et al., 2009). The activated microglia, which were 
immunohistochemically positive for VEGF, may induce further microglial activation in 
the cerebrum of familial dogs with seizures. 
Thus, anigogenesis and microglial activation was thought to be related to seizure-
induced neu
angiogenesis and microglial activation are a cause of seizure-induced neuronal death or 
a subsequent event of seizure-induced neuronal death. However, VEGF-positive cells 
and activated microglia were detected not only in the areas of acute neurona change but 
also in the areas surrounding acute neuronal change. The distribution suggested that 
angiogenesis and microglial activation can accelerate seizure-induce neuronal death and 
expand the lesions. VEGF-induced microglial activation with pro-inflammatory 
cytokine production is thought to play a critical role in neuronal death. Further 
investigation into how microglia are activated and how activated microglia damage 
neurons in an epileptic brain after a seizure is required. These investigations may lead to 
novel therapeutic approaches against the progression of epilepsy. 
FIGURES AND FIGURE LEGENDS 
Fig. 1 Representative images of the cerebrum (cingulate cortex) in a familial dog with 
seizures (No. 3) and a familial dog without seizures (No. 7). Acute neuronal change 
(arrows) is observed in a familial dog with seizures (A). No significant changes were 
observed in a familial dog without seizures (B). H&E stain; b
Fig. 2 Representative images of the cerebrum (cingulate cortex) in a familial dog with 
seizures (No. 1) and a familial dog without seizures (No. 8). Comparing a familial dog 
with seizures (A) and a familial dog without seizures (B), microvessels appeared longer 
and more tortuous in a familial dog with seizures. Oval to flat cells surround the 
microvessel (C), and these cells are positive for vWF (D, arrows) in a familial dog with 
seizures. H&E stain (A-C) and labeled streptavidin-biotin for vWF (D); bars = 
(A, B C), 2 D).  
Fig. 3 Number of microvessels in the cingulate cortex. Comparing with the familial 
dogs without seizures and control dogs, the number was significantly increased in the 
familial dogs with seizures. There are no significant differences in the familial dogs 
without seizures and control dogs. *P<0.05.
Fig. 4 Representative images of cerebrum (cingulate cortex) in a familial dog with 
seizures (No. 2) and a familial dog without seizures (No. 10). Some glial cells (arrows) 
and neurons (arrowheads) are positive for VEGF in a familial dog with seizures (A). 
There are no VEGF-positive cells in a familial dog without seizures (B). Labeled 
streptavidin-biotin for VEG 
Fig. 5 Representative images of cerebrum (cingulate cortex) in a familial dog with 
seizures (No.1). VEGF-positive signals (red signals) are detected in both Iba-1-positive 
microglia (A, green signals) and GFAP-positive astrocyte (B, green signals). Double-
label immunofluorescence; b
Fig. 6 Representative images of cerebrum (cingulate cortex) in a familial dog with 
seizures (No. 2) and a familial dog without seizures (No. 8). Comparing a familial dog 
with seizures (A) and the familial dogs without seizures (B), Iba-1-positive microglia 
increase and have swollen cell bodies and longer processes in the familial dogs with 
seizures (arrows). Labeled streptavidin-biotin for Iba-1; b
Fig. 7 Representative images of cerebrum (cingulate cortex) in a familial dog with 
seizures (No.5).VEGFR-1-positive signals (red signals) are detected in Iba-1-positive 
microglia (A, green signals), and not detected in GFAP-positive astrocyte (B, green 
signals). Double-label immunofluorescence; b
Fig. 8 Representative images of cerebrum (cingulate cortex) in a familial dog with 
seizures (No. 2). TNF- -positive signals (red signals) are detected in Iba-1-positive 
microglia (A, green signals), and not detected in GFAP-positive astrocyte (B, green 
signals). Double-label immunofluorescence; b
Fig. 9 Representative images of cerebrum (cingulate cortex) in a familial dog with 
seizures (No. 1). IL-6-positive signals (red signals) are detected in Iba-1-positive 
microglia (A, green signals) and GFAP-positive astrocyte (B, green signals). Bars = 
Fig. 10 Distribution of the neurons with acute change (black dot) and distribution of 
VEGF-positive cells and activated microglia (gray color) at the coronal level of corpus 
mamillare in the familial dogs with seizures. The distribution of VEGF-positive cells 
and activated microglia was similar to that of neurons with acute change, in addition, 
VEGH-positive cells and activated microglia were also observed in the areas 
surrounding neurons with acute change.  
Fig. 11 Representative images of cerebrum (cingulate cortex) in a familial dog with 
seizures (No. 2) and a familial dog without seizures (No. 10). Neurons (black 
arrowheads) and glial cells (arrows) are positive for IL-6, but neurons with acute change 
(white arrowheads) are negative for IL-6 in a familial dog with seizures (A). There are 
no IL-6-positive cells in the cingulate cortex of the familial dogs without seizures (B). 
Labeled streptavidin-biotin for IL-6; b
Fig. 12 Number of IL-6-positive cells in each severity of acute neuronal change in the 
familial dogs with seizures. Number of IL-6-positive cells is significantly increased in 
the area of more severe acute neuronal change. *P<0.05. 
TABLES 
Table. 1 Primary antibodies used for immunohistochemistry 
Antibody Source Dilution Incubation Supplier 
GFAP Rabbit polyclonal 1:100 10 min in microwave 
Dako, Glostrup, 
Denmark 
Iba-1 Rabbit polyclonal 1:400 10 min in microwave 
Wako Chemicals, 
Richmond, USA 
IL-6 Mouse monoclonal 1:100 overnight at 4 °C Santa Cruz, California, USA 
TNF- Mouse monoclonal 1:300 overnight at 4 °C
Santa Cruz, 
California, USA 
VEGF Mouse monoclonal 1:100 overnight at 4 °C
Abcam, Tokyo, 
Japan 
vWF Rabbit polyclonal 1:100 10 min in microwave 
Dako, Glostrup, 
Denmark 
VEGFR-1 Mouse monoclonal 1:100 overnight at 4 °C
Abcam, Tokyo, 
Japan 
Abbreviations: GFAP, glial fibrillary acidic protein; IL-6, interleukin 6; TNF- , tumor 
necrosis factor alpha; VEGF, vascular endothelial growth factor; vWF, von Willebrand 
factor; VEGFR-1, vascular endothelial growth factor receptor 1. 
CHAPTER 2 
Glutamate transporter 1 downregulation correlates with thalamic neuronal death 
following kainic acid-induced status epilepticus in rat
ABSTRACT 
Recurrent seizures without interictal resumption (status epilepticus) have been 
reported to induce neuronal death in the midline thalamic region that has functional 
roles in memory and decision-making; however, the pathogenesis underlying status 
epilepticus-induced thalamic neuronal death is yet to be determined. We performed 
histological and immunohistochemical studies as well as cerebral blood flow 
measurement using 4.7 tesla magnetic resonance imaging spectrometer on midline 
thalamic region in Sprague Dawley rats (n=67, male, 7 weeks after birth, body weight 
250 - 300 g) treated with intraperitoneal injection of kainic acid (10 mg/kg) to induce 
status epilepticus (n=47) or normal saline solution (n=20). Histological study using 
paraffin-embedded specimen revealed neuronal death showing ischemic-like changes 
and Fluoro-Jade C -positivity with calcium deposition in the midline thalamic region of 
epileptic rats. The distribution of neuronal death was associated with focal loss of 
immunoreactivity for glutamate transporter 1 (GLT-1), stronger immunoreaction for 
glutamate and increase in number of Iba-1-positive microglial cells showing swollen 
cytoplasm and long processes. Double immunofluorescence study demonstarted co-
expression of interleukin-1 beta (IL- e synthase (iNOS) 
within microglial cells, and loss of GLT-1-immunoreactivity in reactive astrocytes. 
These microglial alterations and astrocytic GLT-1-downregulation were also observed 
in tissue without obvious neuronal death in kainic acid-treated rats. These results 
suggest the possible role of glutamate excitotoxicity in neuronal death in the midline 
thalamic region following kainic acid-induced status epilepticus due to astrocytic GLT-
1 downregulation following microglial activation showing upregulation of IL-1  and 
iNOS. 
INTRODUCTION 
Epilepsy is a chronic neurological condition characterized by recurrent seizures due 
to neuronal hyperexcitation (Blume et al., 2001). The prevalence of epilepsy in general 
has been reported between 4 to 10 per 1,000 persons (Sander et al., 2003).
Approximately 30 percent of epilepsy patients do not have seizure remission despite 
appropriate medical treatment (Kwan et al., 2000). Patients with intractable epilepsy 
also suffer from sequellae of brain dysfunctions including memory loss, language 
impairment, depression and olfactory dysfunction (Alessio et al., 2006; Jacek et al., 
2007; Kanner et al., 2011)
mbic system (Fujikawa et al., 
2000; Meldrum et al., 1993).
Classical experimental studies have shown that systemic injection of kainic acid, a 
glutamate receptor agonist, in rodents induces seizures and epileptiform discharges in 
the hippocampus that propagate to other limbic structures (Pinheiro et al., 2006), and 
neuronal death in the cornu ammonis of the hippocampal formation, piriform cortex, 
and specific nuclei of the thalamus (Gayoso et al., 2003). Status epilepticus-induced 
neuronal death is frequently observed in the midline region, particularly the 
mediodorsal nucleus (MD) and nucleus reuniens (Re) in the thalamus (Gayoso et al., 
2003). The MD and Re are thought to play functional roles in memory, olfactory 
perception and decision-making in human and animals (McKenna et al., 2004; Tham et 
al., 2009; Vertes et al., 2002). Magnetic resonance imaging (MRI) analyses have 
demonstrated thalamic volume reduction in epilepsy patients (Helms et al., 2006; 
Natsume et al., 2003), however, there are few reports on the pathogenesis of status 
epilepticus-induced neuronal death in the thalamus (Ingvar et al., 1988). We performed 
histological and immunohistochemical studies as well as cerebral blood flow 
measurement using 4.7 tesla MRI spectrometer on midline thalamic region in kainic 
acid-induced status epilepticus in Sprague Dawley rats to investigate the pathogenesis 
of status epilepticus-induced neuronal death in the thalamus, focusing on glutamate 
transporter 1 (GLT-1) downregulation and microglial activation, that are recently 
reported in the epileptic brains (Najjar et al., 2011; Proper et al., 2002). 
MATERIALS AND METHODS 
Animals  
Sixty-seven Sprague Dawley rats (7 weeks old, male, body weight 250 - 300 g, 
CLEA Japan Inc., Tokyo, Japan) were used in this study. Animals were maintained at a 
constant temperature (25°C) and humidity (55 - 70%) under a 12/12 h light/dark cycle 
with free access to food and water. The study was carried out with the approval of the 
Animal Research Committee, in accordance with the guidelines for animal experiment 
of the Faculty of Agriculture, Tottori University.
Induction of status epilepticus 
Forty-seven rats were subjected to intraperitoneal injection of kainic acid (5 mg/ml 
in saline, 10 mg/kg; Sigma-Aldrich, St. Louis, USA) to induce status epilepticus, and 20 
animals were treated with the same volume of normal saline solution (Otsuka Seiyaku, 
Tokyo, Japan) as controls. The induction of status epilepticus was judged using the 
behavioral scale proposed by Zhang and colleagues (Zhang et al., 1997). In brief, the 
epileptic convulsion profile of rats was classified according to 6 distinct stages 
characterized by; stage 1, immobilization, staring, mouth and facial movements; stage 2, 
wet dog shakes; stage 3, forelimb clonus and head nodding; stage 4, rearing; stage 5, 
rearing and falling; and stage 6, jumping and circling. Kainic acid-treated rats that 
exhibited at least stage 4 convulsions were judged as having status epilepticus in this 
study. The rats having status epilepticus (n=27) were kept for 0 day (5 hours after kainic 
acid injection; n=5), 7 (n=9), 14 (n=8) and 28 days (n=5). The rats without status 
epilepticus (n=20) and saline-treated controls (n=20) were also kept in the same manner 
(n=5 for each maintenance period). During the maintenance period, the rats having 
status epilepticus were monitored by a video camcorder for 24 hours a day.  
Cerebral blood flow measurement 
Cerebral blood flow (CBF) measurement was performed on 4 rats having status 
epilepticus and 4 rats without status epilepticus, by means of continuous arterial spin 
labeling (CASL) method with a labeling neck coil (Rapid Biomedical GmbH, Rimpar, 
Germany) using a 4.7 tesla MRI spectrometer (Unity Inova, Varian Inc., California, 
USA). The rats which exhibited status epilepticus (rearing) were anesthetized and set in 
the bore. Animals were anesthetized with isoflurane (0.5 1.5% with a 1:9 ratio of 
oxygen and room air) throughout the experiment. CBF was measured on the coronal 
plane including MD and Re determined by referencing to the T2-weighted images and a 
stereotaxic atlas. Magnetic resonance images for CASL were acquired using a gradient 
echo sequence with the following characteristics: response time, 8 ms; echo time, 4 ms; 
field of view, 25 mm; matrix size, 64 x 64. A post delay of 400 ms was used for CASL 
CBF imaging. CASL CBF was calculated in accordance with the previous reports 
(Nakamura et al., 2008). The kainic acid-treated rats without status epilepticus were 
subjected to CBF measurement 90 min after the drug injection. The average of CASL 
CBF in each rat was measured in the areas of interest including MD and Re. Mann
Whitney test was used for statistical analysis of the data between rats with and without 
status epilepticus.  
Histological and immunohistochemical studies 
Under deep anesthesia with intraperitoneal injection of sodium pentobarbital (64.8 
mg/kg, Kyoritsu Seiyaku, Tokyo, Japan), brains were removed and fixed in 10% neutral 
phosphate-buffered formalin for 72 hours, and cut coronally with 2 mm intervals. The 
specimens were embedded in paraffin wax and sectioned at 4 µm for hematoxylin and 
eosin, Alizarin Red S (Kanto Chemical Co., Inc., Tokyo, Japan) (Dahl, 1952), and 
Fluoro-Jade C (Chemicon, Temecula, CA, USA) stainings as well as 
immunohistochemical studies using the following primary antibodies; Iba-1 (mouse 
monoclonal, clone 1022-5, dilution 1:200; Abcam, Tokyo, Japan), glial fibrillary acidic 
protein (GFAP; mouse monoclonal, clone 6F2, dilution 1:200; Dako, Glostrup, 
Denmark), GLT-1 (rabbit polyclonal, dilution 1:500; Wako Chemicals, Richmond, 
USA), and glutamate (mouse monoclonal, clone GLU-4, dilution 1:400; Sigma-
Aldrich). After deparaffinization, the sections were subjected to microwave irradiation 
in sodium citrate buffer (pH 6.0) for 20 min at 98°C in a microwave processor (MI-77, 
Azumaya inc., Tokyo, Japan). Subsequently, after blocking endogenous peroxidase 
activity with 3% hydrogen peroxide for 15 min, sections were preincubated with 10% 
normal goat serum for 5 min in the microwave processor. Then, the sections were 
incubated with primary antibodies for overnight at 4°C for glutamate, and for 10 min 
under continuous microwave irradiation for Iba-1, GFAP and GLT-1. Sections were 
incubated with appropriate goat anti-rabbit or anti-mouse immunoglobulins conjugated 
to peroxidase labeled-dextran polymer (EnVision+ System-HRP, Dako, Carpinteria, 
CA, USA) for 30 min at room temperature (approx. 20°C). The immunoreaction was 
visualized using 3,3 -diaminobenzidine tetrahydrochloride (Dako, Carpinteria, CA, 
USA). Sections were finally counterstained with hematoxylin. For double 
immunofluorescence studies, sections were incubated with a mouse monoclonal anti-
Iba-1 antibody or a mouse monoclonal anti-GFAP antibody for 10 min in the 
microwave processor, followed by incubation with an Alexa Fluor 555-conjugated 
donkey anti-mouse IgG antibody (dilution 1:200; Life Technologies, Carlsbad, USA) 
for 1 hour at room temperature. Sections were then incubated with rabbit polyclonal 
antibodies for GLT-1, interleukin-1 beta (IL-1 ; dilution 1:50; Santa Cruz, California, 
USA), or inducible nitric oxide synthase (iNOS; dilution 1:100; Abcam) for overnight at 
4°C, followed by incubation with an Alexa Fluor 488-conjugated goat anti-rabbit IgG 
antibody (dilution 1:200; Life Technologies) for 1 hour at room temperature. Sections 
were mounted in plain 80% Tris-buffered glycerol and observed under a fluorescence 
microscope (AX-70, Olympus Corporation, Tokyo, Japan). Appropriate positive 
controls were carried out by omission of the primary antibodies replacing with 
phosphate-buffered saline. 
Morphometry and statistical analysis 
For morphometry and statistical analysis, the sections that include MD and Re were 
selected based on the stereotaxic atlas of the rat brain (Paxions et al., 1986), and the 
areas of MD and Re were defined by the coordinate system (x, y). Y-axis was set 
parallel to the fissura longitudinalis cerebri, and X-axis intersected at a right angle with 
the Y-axis. The point (0, 0) was located at the midline lower end of the section. The 
rectangles made from the following 4 points were defined in the area of MD: (-1.2 mm, 
5.1 mm), (-1.2 mm, 4.4 mm), (1.2 mm, 4.4 mm) and (1.2 mm, 5.1 mm). Also, the 
rectangles made from the following 4 points were defined in the area of Re: (-0.8 mm, 
3.4 mm), (-0.8 mm, 3.2 mm), (0.8 mm, 3.2 mm) and (0.8 mm, 3.4 mm). All bright-field 
photographs were taken by the digital camera (DP-21, Olympus, Tokyo, Japan) attached 
to the light microscope (BX-51, Olympus).  
The percentage of GLT-1-immunoreactive area (GLT-1-IRA%) was calculated in 
each rat by means of computer-assisted image analysis using Image-Pro® (Nippon 
Roper, Tokyo, Japan) software using the digital images taken with x10 objective lens 
(1.3 mm2).  
The total number of Iba-1-positive microglia and the percentage of morphologically 
activated microglia were manually counted and calculated in the MD and Re of each rat 
using the 5 non-overlapping digital images in each nucleus taken with x40 objective 
lens (0.1 mm2). The average number of microglia per 1 mm2 was counted in each rat, 
and semiquantitative evaluation was performed according to the following criteria; i.e., 
mild increase  when more than 200 but less than 400 microglial cells per 1 mm2 were 
observed, and marked increase  when the number was 400 or more.  
For each group (rats having status epilepticus, rats without status epilepticus and 
controls), the mean values of the GLT-1-IRA% and the number of Iba-1-positive 
microglia at each time point were statistically compared by Kruskal Wallis test. At each 
time point, the difference among the rats having status epilepticus, the rats without 
status epilepticus, and controls was analyzed using the analysis of variance followed by 
a post hoc Scheffe s test for multiple comparisons. The statistical difference was 
considered to be significant when the p value was less than 0.05. 
The number of GFAP-positive reactive astrocytes (having swollen cytoplasm, thick 
short processes, and occasional multiple nuclei) were counted in MD and Re in each rat, 
and judged as mild increase  when the number of reactive astrocytes was less than 15, 
and marked increase  for the number of 15 or more. 
RESULTS 
Induction of status epilepticus 
Twenty-seven of 47 rats (57.4%) with kainic acid injection started to show wet dog 
shakes at 30 to 60 min after treatment. Within 180 min after injection, they showed 
recurrent rearing (classified as e). A rearing was maintained for 
30-180 sec and sometimes lead to falling (stage 5). Rearing completely disappeared 
within 5 hours after injection. 27 rats having status epilepticus were divided and kept for 
0 day (5 hours after kainic acid injection, n=5), 7 (n=9), 14 (n=8) and 28 days (n=5). 
During the maintenance period, recurrent spontaneous seizures were absent as long as 
the observation through video camcorder. No rats died during the maintenance period. 
Other 20 rats with kainic acid injection and saline-treated controls did not show any 
behavioral alterations. 
CBF measurement 
The means and standard deviation of CASL CBF in the midline thalamic region 
were 76.3±17.9 (4 rats having status epilepticus) and 93.3±7.5 (4 rats without status 
epilepticus). There were no statistically significant differences in the CBF measurement 
data between them (Fig. 1). 
Histological findings (Table 1) 
In the brains of rat showing status epilepticus (5 rats in day 7, 5 rats in day 14 and 5 
rats in day 28), both intracellular and extracellular calcifications were observed in MD 
and Re (Fig. 2A). These calcifications were strongly positive for Alizarin Red S 
staining. Within the lesions, neurons exhibited ischemic-like changes showing shrunken 
eosinophilic cytoplasms and karyolysis (Fig. 2B), and Fluoro-Jade C staining-positive 
degenerating neurons were observed. On the other hands, there were no significant 
histological changes in all rats without status epilepticus and control animals. Based on 
these findings, status epilepticus-induced neuronal death in the MD and Re was 
confirmed.  
Immunohistochemical findings (Table 1) 
Glutamate: GLT-1 immunoreactivity was focally decreased in MD and Re of rats 
having status epilepticus (Figs. 3A, B). The focal loss of GLT-1 immunoreactivity was 
colocalized with the lesion showing neuronal death. In addition, there was a mosaic-like 
loss of GLT-1 immunoreactivity in MD and Re of rat having status epilepticus without 
obvious neuronal death (2 rats in day 7 and 3 rats in day 14). Other rats having status 
epilepticus did not show any immunohistochemical difference compared with the rats 
without status epilepticus and controls, showing diffuse GLT-1 immunopositivity in the 
cytoplasm and process of astrocytes. Within the lesions showing neuronal death, there 
was a focal glutamate immunopositivity in the neuropil (Figs. 3C, D). No glutamate 
immunoreactivity was detected in other rats having status epilepticus, and rats without 
status epilepticus as well as controls.  
Temporal decrease in the GLT-1-IRA% was observed in both MD and Re of rats 
having status epilepticus (p<0.05). Significant decrease in GLT-1-IRA% was observed 
(p<0.05) in MD and Re of rats having status epilepticus compared with the rats without 
status epilepticus and controls at day 14 and 28 (Fig. 4). There was no significant 
difference in GLT-1-IRA% between rats without status epilepticus and controls at each 
time point. 
Microglia: Increased number of Iba-1-positive microglia was a characteristic finding in 
MD and Re of rats having status epilepticus, except day 0 group (Fig. 5A). In addition, 
Iba-1-positive microglia exhibited an activated shape (swollen cell bodies and long 
processes) (Fig. 5B). Double immunofluorescence revealed extensive IL-1 - and iNOS- 
immunolabelings in Iba-1-positive microglial cells of activated shape (Fig. 6). Temporal 
increase in the number of Iba-1-positive microglia was observed in both MD and Re of 
rats having status epilepticus (p<0.05). Significant increase in number of microglia was 
statistically confirmed (p<0.05) at all time points except day 0, in MD and Re of rats 
having status epilepticus compared with the rats without status epilepticus and controls  
(Fig. 7). 
Astrocytes: Increased number of GFAP-positive astrocytes was observed in MD and 
Re of rats having status epilepticus, particularly in the peri-lesional area (Fig. 8A). In 
the center of the lesion, reactive astrocytes showing swollen cytoplasm, thick short 
processes, and occasional multiple nuclei (Fig. 8B) were observed only in rats having 
status epilepticus (5 rats in day 7, 8 rats in day 14 and 5 rats in day 28). Double 
immunofluorescence did not show GLT-1-, IL-1  and iNOS immunolabelings in these 
reactive astrocytes. 
DISCUSSION 
In this study, status epilepticus-induced neuronal death was indicated by the 
morphological (ischemic-like) changes of neurons and Fluoro-Jade C staining in the 
midline thalamic region, particularly in the MD and Re. These findings coincide with a 
previous report (Gayoso et al., 2003). Although seizure-induced neuronal injury was 
-
ischemic, seizure activity-induced irreversible neuronal injury (Meldrum et al., 1992). 
CBF measurement in our study also suggested no CBF alterations immediately after 
status epilepticus. Recent studies have supported the concept that the thalamus, 
particularly the midline thalamic region, is a part of the epileptic circuits of temporal 
lobe epilepsy (Bertram, 2012). Neuronal death in the midline thalamic region of kainic 
acid-treated rat might be triggered by status epilepticus.  
Decrease in GLT-1 immunopositive area and microglial activation were 
characteristic findings within the lesion. In addition, time-dependent decrease in GLT-1 
immunopositive area and microglial activation were observed after status epilepticus. 
These changes, together with the fact that GLT-1 downregulation were also observed in 
the lesions without neuronal death (2 rats in day 7 and 3 rats in day 14), suggest the 
important preceding mechanism for inducing neuronal death.  
The decrease in GLT-1 immunopositive area observed in the present study was 
largely attributable to the astrocytic GLT-1 downregulation. Immunohistochemically, 
GFAP-positive, but GLT-1-negative, reactive astrocytes were present in the lesion. 
GLT-1 is a transporter that is important for astrocytic glutamate uptake in synaptic 
clefts and expressed in astrocytic foot processes (Anderson et al., 2000). The lesion 
showing neuronal death and focal decrease in GLT-1 immunopositive area was always 
associated with a strong glutamate immunoreactivity in the neuropil, while no glutamate 
immunopositivity was observed in the lesion without apparent neuronal death. These 
findings suggest that an excessive glutamate accumulation in the synaptic cleft due to 
astrocytic GLT-1 downregulation resulted in excitotoxic neuronal death (Anderson et 
al., 2000; Rodríguez et al., 2000). Recent studies have shown that GLT-1 is crucial for 
neuronal survival (Rao et al., 2001). Futhermore, neuronal death in MD and Re was 
always associated with calcium deposition as revealed by Alizarin Red S staining. 
Excess glutamate stimulates its receptors and leads to neuronal hyperexcitation because 
of intracellular calcium-ion overload (Choi et al., 1988). For this reason, it has been 
proposed that neuronal death caused by glutamate excitotoxicity is associated with 
intracellular and extracellular calcification (calcium deposition) (Gayoso et al., 2003; 
Rodríguez et al., 2000).Thus, the downregulation of astrocytic GLT-1 resulting in 
glutamate excitotoxicity was considered as a cause of status epilepticus-induced 
neuronal death in MD and Re of kainic acid-treated rats. GLT-1 downregulation has 
been reported in the hippocampus of both human epilepsy patients and animal models 
of epilepsy (Proper et al., 2002; Ueda et al., 2001). Furthermore, increased levels of 
glutamate in the thalamus and atrophy of this brain structure have been reported in 
epileptic patients (Helms et al., 2006; Natsume et al., 2003). Kainic acid is an agonist of 
glutamate receptors and has excitotoxicity (Pinheiro et al., 2006). However, in this 
study, there were no neuronal death and other significant changes in the brains of all rats 
without status epilepticus despite the kainic acid injection. 
Another characteristic finding in the lesions of MD and Re was microglial 
activation. The increased number of Iba-1-positive microglia and morphological 
changes in microglia (swollen cell bodies and long processes) as well as upregulation of 
IL-1  and iNOS indicate microglial activation (Avignone et al., 2008). And these 
changes preceded the decrease in GLT-1 immunopositive area (as it appeared in 2 rats 
of day 7). Recent studies have shown that astrocytic GLT-1 downregulation is mediated 
by IL-1  and nitric oxide (synthesized by iNOS) (Yamada et al., 2006; Prow et al., 
2008). Accordingly microglial activation might cause astrocytic GLT-1 downregulation 
in the midline thalamic region of kainic acid-treated rats. Although, IL-1  and nitric 
oxide have been reported to have direct neurotoxicity, including excitotoxicity (Brown 
et al., 2010; Lau et al., 2010; Rijkers et al., 2009), no neuronal death was detected in the 
MD and Re of 5 rats having status epilepticus, despite the presence of activated 
microglia with IL-1  and iNOS expression. A growing number of evidence suggests 
that microglial activation is induced by status epilepticus, and a purinergic stimulus by 
adenosine triphosphate (ATP) is thought to be important for the microglial activation 
(Avignone et al., 2008; Shapiro et al., 2008; Somera-Molina et al., 2009). Neuronal 
hyperexcitation has been reported to be associated with astrocytic ATP release, which 
can induce microglial activation and IL-1  release (Färber et al., 2006; Schipke et al., 
2002; Seifert et al., 2010). As described above, the midline thalamic region is reported 
to be involved in epileptic circuits. Although we were able to show few evidences, 
neuronal hyperexcitation associated with astrocytic ATP release might trigger 
microglial activation in the midline thalamic region during status epilepticus. 
   In conclusion, this study demonstrated the presence of status epilepticus-induced 
neuronal death that seemed to be caused by glutamate excitotoxicity. Histological and 
immunohistochemical findings suggested that microglial activation associated with IL-
1  and iNOS expressions was responsible for astrocytic GLT-1 downregulation, 
resulting in glutamate excitotoxicity  
FIGURES AND FIGURE LEGENDS 
Figure 1. Representative image of cerebral blood flow measurements. There are no 
significant differences in the CBF images in the midline thalamic region (in the black 
frames) between the rats having status epilepticus and the rats without status epilepticus. 
Figure 2. Neuronal death with calcification in the nucleus reuniens of rat having status 
epilepticus. Extracellular calcification (A, B, arrows) and neurons exhibiting ischemic-
like changes (shrunken eosinophilic cytoplasm and karyolysis are present in the lesion 
(B, arrowheads). Hematoxylin and eosin staining. Bars, 100 µm (A) and 20 µm (B). 
Figure 3. Immunohistochemical expression of glutamate transporter 1 (GLT-1) and 
glutamate in the nucleus reuniens of rat having status epilepticus. GLT-1 
immunoreactivity is focally decreased (A). There is a small number of GLT-1-positive 
astrocytes (B, arrow). Strong glutamate immunoreactivity is observed and confined to 
the lesion (C). The glutamate immunoreactivity is observed in the neuropil (D, arrows). 
Immunohistochemistry for GLT-1 (A, B) and for glutamate (C, D). Bars, 100 µm (A, C) 
and 20 µm (B, D). 
Figure 4. The percentage of glutamate transpoter 1 (GLT-1) immunopositive area in the 
mediodorsal nucleus (MD) and nucleus reuniens (Re). The data represent mean values 
standard deviation. *P < 0.05. Abbrev. SE -, rats without status epilepticus; SE +, rats 
having status epilepticus.  
Figure 5. Microglial proliferation in the nucleus reuniens of rat having status 
epilepticus. Note focal accumulation of Iba-1-positive microglial cells within the lesion 
(A), mostly showing an activated shape (swollen cell bodies and long processes) (B, 
arrow). Immunohistochemistry for Iba-1. Bars, 100 µm (A), 20 µm (B). 
Figure 6. Expressions of interleukin-1 beta (IL-1 ) and inducible nitric oxide synthase 
(iNOS) in microglial cells in the midline thalamic regions. Double immunofluorescence 
for Iba-1 (magenta), and IL-1  (A) or iNOS (B) (green). Bars, 10 µm.
Figure 7. The number of Iba-1-positive microglia in the mediodorsal nucleus (MD) and 
nucleus reuniens (Re). The data represent mean values  standard deviation. *P < 0.05. 
Abbrev. SE -, rats without status epilepticus; SE +, rats having status epilepticus.  
Figure 8. Reactive astrocytes in the nucleus reuniens of rat having status epilepticus. 
Glial fibrillary acidic protein (GFAP) immunoreactivity is detected in reactive 
astrocytes in the lesion, whereas proliferation of GFAP-positive astrocytes are observed 
in the peri-lesional area (A). Note GFAP-positive reactive astrocytes showing swollen 
cytoplasm, thick short processes and occasional multiple nuclei (B, arrows) within the 
lesion. Immunohistochemistry for GFAP (A, B). Bars, 100 µm (A), 20 µm (B). 
Tables 
Table 1. Summary of the histological and immunohistochemical findings in the 
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ischemic-like changes and Fluoro-Jade C staining-positive cells. The column for 
number of Iba-1-positive microglia per 1 mm2
more. the number of GFAP-positive 
astrocytes showing swollen cytoplasm, thick short processes, and occasional multiple 
observed with x40 objective lens. The coloum for GLT-1 represents the percentage of 
glutamate transporter 1-immunoreactive area calculated by means of computer-assisted 
image analysis using the digital images taken with x10 objective lens (1.3 mm2)
45% or less. 
GENERAL DISCUSSION AND CONCLUSION 
   In the first chapter, the relationship of angiogenesis and microglial activation to 
seizure-induced neuronal death associated with GLT-1 downregulation in the cerebrum 
of familial epileptic Shetland Sheepdogs was demonstrated (Figure 1). Consistent 
distribution of angiogenesis and microglial activation indicates the relationship to 
seizure-induced neuronal death. Microglial activation may have a major role in the 
GLT-1 downregualtion. Further, VEGF-expression associated with angiogenesis might 
enhance and spread the microglial activation.  
TNF- , which was expressed in the activated microglia in the cerebrum of Shetland 
Sheepdogs, is thought to be responsible for GLT-1 downregration. Microglia are 
resident immune cells in the central nervous system (Graeber et al., 2010). Activated 
microglia express pro-inflammatory cytokines, as well as in this study (Graeber et al., 
2010). TNF- , a pro-inflammatory cytokine expressed in the activated microglia of 
familial Shetland Sheepdogs, has been reported to induce GLT-1 downregulation that 
results in neuronal death (Carmen et al., 2009).  
   VEGF-expression is thought to enhance and spread the microglial activation in and 
around the lesions of familial Shetland Sheepdogs. VEGF is sometimes called as a 
double edged-sword in the brain after seizures, because the role of VEGF is either 
protective (e.g. angiogenesis) or destructive (e.g. neuroinflammation) (Croll et al., 
2004). In this study, VEGF-expression in neurons and glial cells (astrocytes and 
microglia) is firstly considered to induce angiogenesis for protection of neurons, 
however, VEGFR-1-expression in the activated microglia suggests an induction of 
microglial activation by VEGF. VEGF has been reported to activate microglia via 
VEGFR-1 and induce an inflammatory response which includes expression of TNF-
and IL-6 (Croll et al., 2004; Forstreuter et al., 2002; Yoo et al., 2005). In the cerebrum 
of the familial Shetland Sheepdogs, VEGF expressed in neurons and glial cells could 
activate microglia and induce overexpression of pro-inflammatory cytokines. In 
addition, the distribution of VEGF-positive cells and activated microglia around the 
lesions where neuronal death was not observed suggests that VEGF has a role in the 
expansion of the lesion via microglial activation. 
In the second chapter, the progress of the lesion of seizure-induced neuronal death in 
the thalamus of kainic acid-treated rat was demonstrated. GLT-1 downregulation and 
microglial activation are considered as a cause of seizure-induced neuronal death 
(Figure 2). From day 7 after induction of seizures, the seizure-induced neuronal death 
was found in the midline thalamic regions. These thalamic regions were always 
associated with the GLT-1 downregulation and microglial activation. Further, some 
animals at day 7 showed mild GLT-1 downregulation and microglial activation in the 
midline thalamic regions without neuronal death. 
GLT-1 downregulation can cause neuronal death due to glutamate excitotoxicity 
(Anderson et al., 2000; Rodríguez et al., 2000). Immunohistochemically, accumulation 
of glutamate is suggested in the lesions of neuronal death. It has been reported that 
neuronal death caused by glutamate excitotoxicity is frequently associated with 
calcification (calcium deposition), as well as in this study (Gayoso et al., 2003; 
Rodríguez et al., 2000).  
Pro-inflammatory cytokines and nitric oxide induced by the activated microglia in 
the lesion might be responsible for the GLT-1 downregulation. Both IL-1  and nitric 
oxide has been reported to induce GLT-1 downregulation (Yamada et al., 2006; Prow et 
al., 2008). Though the pathogenesis is not known in detail, seizures have been reported 
to activate microglia (Avignone et al., 2008). 
In summary, glutamate toxicity due to GLT-1 downregulation is considered to be a 
cause of seizure-induced neuronal death in the cerebrum of both familial epileptic 
Shetland Sheepdogs and the thalamus of kainic acid-treated rats. In addition, 
neuroinflammation, particularly microgrial activation, may induce GLT-1 
downregulation in the brain after epileptic seizures.  
   In conclusion, this study demonstrated that seizure can induce various pathological 
changes including both neuroprotective (angiogenesis) and neurodestructive (microglial 
activation and GLT-1 downregulation). These changes were considered to a cause of 
seizure-induced neuronal death resulting in the sequellae of brain dysfunctions (Figure 
3). However, the current studies did not investigate other possible mechanisms of 
seizure-induced neuronal death (e.g. hypoperfusion, blood-brain barrier breakdown, 
neuroinflammation). Further study on prolonged period after seizure, other animals and 
animal models of epilepsy are needed. Seizure-induced neuronal death is considered to 
be caused as a result of various pathologic changes after seizures. Further study is 
required for the individual pathologic changes. 
Figure 1. Schematic diagram shows the normal relationship among neuron, glial cells 
and blood vessels in the cerebrum of familial Shetland Sheepdogs without seizures 
(above) and the possible mechanism of seizure-induced neuronal death in the familial 
Shetland Sheepdogs with seizures (below).   
Figure 2. Schematic diagram shows the normal synaptic cleft of the rat without seizures 
(above) and the possible mechasim of seizure-induced neuronal death in the cerebrum 
of rat with seizures (below).  
Figure 3. Schematic diagram shows the possible risk of epileptic seizures. Epileptic 
seizures can induce several pathological changes, which have neuroprotective or 
neurodestructive effects, in the cerebrum. The neurodestrcutive effects sometimes result 
in seizure-induced neuronal death. 
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